Invention Grant
- Patent Title: Treatment of obesity in subjects having variant nucleic acid molecules encoding Calcitonin Receptor (CALCR)
-
Application No.: US17401679Application Date: 2021-08-13
-
Publication No.: US11939635B2Publication Date: 2024-03-26
- Inventor: Luca Andrea Lotta , Parsa Akbari , Manuel Allen Revez Ferreira , Aris Baras
- Applicant: Regeneron Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: Armstrong Teasdale LLP
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12P19/34 ; C12Q1/6883
Abstract:
The present disclosure provides methods of treating subjects having obesity and/or increased body mass index (BMI), and methods of identifying subjects having an increased risk of developing obesity and/or BMI.
Information query
